17 research outputs found

    Host response to lung-specific delivery of <i>B. pseudomallei</i>.

    No full text
    <p>Groups of 5 female albino C57BL/6J mice were challenged with increasing doses of luminescent <i>B. pseudomallei</i> strain JW280 by either the intranasal (A) or IMIT (B) routes of infection. Mice were monitored for 14 days (336 hr) for disease progression and euthanized at the onset of moribund disease presentation. Survival curves are used to present the dose-dependent response of the host to increasing bacterial challenges. The MTTD was calculated for groups with ≥50% mortality, as indicated.</p

    Bacterial enumeration at moribund disease for respiratory melioidosis models.

    No full text
    <p>Groups of 5 female albino C57BL/6J mice were infected by either the i.n. (10<sup>5.1</sup> CFU) or IMIT (10<sup>4.6</sup> CFU) routes of infection and euthanized at moribund disease endpoints. Bacteria were enumerated from tissues homogenized in 1 ml PBS, from a 1 ml PBS BAL collection, or from cardiac-drawn blood. Bacterial burden was calculated as CFU/tissue (lung, liver, and spleen) or bacteria per ml of body fluid (BAL and blood). Significant differences between log transformed data were evaluated by 2-way ANOVA with Bonferroni multiple comparisons (n.s., not significant; *, p<0.05; **, p<0.01; ****, p<0.0001).</p

    Male host response to lung-specific delivery of <i>B. pseudomallei</i>.

    No full text
    <p>Groups of 3 male albino C57BL/6J mice were challenged with increasing doses of luminescent <i>B. pseudomallei</i> strain JW280 by IMIT infection. Mice were monitored for 14 days (336 hr) for disease progression and euthanized at the onset of moribund disease presentation. Survival curves are used to present the dose-dependent response of the host to increasing bacterial challenges. The MTTD was calculated for groups with ≥50% mortality, as indicated.</p

    Bacterial enumeration of <i>B. pseudomallei</i> mutants in moribund respiratory disease.

    No full text
    <p>Groups of 5 female albino C57BL/6J mice were infected with wild type JW280 (10<sup>4.2</sup> CFU), Δ<i>wcb</i> capsule mutant (10<sup>6.0</sup> CFU), or Δ<i>sctU</i>Bp3 T3SS3 mutant (10<sup>6.5</sup> CFU), and euthanized at moribund disease endpoints. Bacteria were enumerated from tissues <i>ex vivo</i> by optical imaging (left Y-axis: cps/tissue) with presentation of the estimated tissue CFU burdens based on calculated tissue-specific cps:CFU correlation (right Y-axis: CFU/tissue est.) for lung (A), liver (B) and spleen (C). The 95% LOD was calculated as a technical background luminescence and indicated as a dotted horizontal line. Data points below the 95% LOD were set to the 95% LOD value. Significant differences (1-way ANOVA with Tukey posttest) between log transformed data sets are indicated with an adjoining line (*, p<0.05; **, p<0.01; ***, p<0.001).</p

    Detection of pulmonary growth rates of <i>B. pseudomallei</i> mutants <i>in vivo</i>.

    No full text
    <p>Groups of 5 female albino C57BL/6J mice were infected with wild type JW280 (10<sup>4.2</sup> CFU), Δ<i>wcb</i> capsule mutant (10<sup>6.0</sup> CFU), or Δ<i>sctU</i>Bp3 T3SS3 mutant (10<sup>6.5</sup> CFU), and monitored by optical diagnostic imaging once to twice daily. ROIs from the dorsally-imaged thoracic cavity were plotted as a function of infection time for each mutant. The 95% LOD was calculated for the background luminescence of uninfected mice and indicated as a dotted horizontal line. The calculated doubling rate of bioluminescent signal of each strain is indicated.</p

    Host response to capsule and T3SS3 mutants of <i>B. pseudomallei</i>.

    No full text
    <p>Groups of 5 female albino C57BL/6J mice were challenged by the IMIT route of infection with increasing doses of either Δ<i>wcb</i> capsule mutant (A) or Δ<i>sctU</i><sub>Bp3</sub> T3SS3 mutant (B) in the luminescent <i>B. pseudomallei</i> strain JW280 background. Mice were monitored for 14 days (336 hr) for disease progression and euthanized at the onset of moribund disease presentation. Survival curves are used to present the dose-dependent response of the host to increasing bacterial challenges of <i>B. pseudomallei</i> mutants. The MTTD was calculated for groups with ≥50% mortality, as indicated.</p

    Detection of dissemination of <i>B. pseudomallei</i> mutants by optical imaging.

    No full text
    <p>Groups of 5 female albino C57BL/6J mice were challenged by the IMIT route of infection with either wild type luminescent <i>B. pseudomallei</i> strain JW280, the Δ<i>wcb</i> capsule mutant, or the Δ<i>sctU</i><sub>Bp3</sub> T3SS3 mutant. Representative images of disease endpoints are presented, with uniform image settings adjusted to a range of 2.5×10<sup>3</sup> to 3×10<sup>4</sup> p/s/cm2/sr on a logarithmic scale.</p

    Uptake of <i>K. pneumoniae</i> wild type and capsular polysaccharide mutants strains into cultured murine macrophages.

    No full text
    <p><i>K. pneumoniae</i> strains ATCC 43816 (K2), NTUH-K2044 (K1) and MGH 78578 (K52) or capsule mutants ATCC Δ<i>manC</i>, and NTUH Δ<i>wzc</i> were incubated in the presence of cultured murine macrophage cell lines J774A.1 or RAW264.7 at an MOI of 10 in 96 well plates. At one hour post-infection, gentamicin was introduced to eradicate extracellular bacteria, and uptake of <i>K. pneumoniae</i> strains into macrophages was assessed at 3 hr post-infection by plate counting. Triplicate samples were enumerated and data analyzed as a percentage of the inoculum, with the results representative of at least two independent trials.</p

    Bacterial burden of <i>K. pneumoniae</i>-infected mice.

    No full text
    <p>Groups of five female BALB/c mice were infected with <i>K. pneumoniae</i> strains ATCC 43816 or NTUH-K2044 and tissues were harvested at the onset of moribund disease, and homogenized in 1 ml of PBS Bacteria were enumerated from blood and from homogenates of lung, liver, and spleen. The results present a min/max box and whisker plot for each infected tissue (n = 5). Statistical analysis was carried out by one way ANOVA and Tukey post test.</p

    Negative staining of capsular polysaccharide from ATCC 43816 and NTUH-K2044 strains.

    No full text
    <p>Overnight bacterial suspensions of ATCC 43816 (A), ATCC Δ<i>manC</i> (B), NTUH-K2044 (C) and NTUH Δ<i>wzc</i> (D) were mixed in 1∶1 ratio with 10% nigrosin. The loss of the capsular polysaccharide from the mutant strains were illustrated by the decrease exclusion of the nigrosin dye which was visualized with Zeiss Axio microscope (63x magnification). Imaris analysis identified that the cross-sectional areas of ATCC Δ<i>manC,</i> and NTUH Δ<i>wzc</i> mutants were reduced by 36.21%, and 28.59%, relative to their isogenic parents.</p
    corecore